Skip to main content

Table 5 Comparison of P-cadherin expression in different breast cancer subtypes

From: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

 

IBC

Non-IBC

p-value

 

n(%)

n(%)

 

Basal cases (ER-,ERBB2-)

18/19(95%)

35/51(69%)

0.05

ERBB2-overexpressing cases

9/13(69%)

32/47(68%)

NS

Luminal cases (ER+, PR+)

14/17(82%)

84/197(43%)

<0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us